MARKET

NRXP

NRXP

Nrx Pharmaceuticals Inc
NASDAQ
2.360
-0.080
-3.28%
After Hours: 2.340 -0.02 -0.85% 19:31 12/05 EST
OPEN
2.420
PREV CLOSE
2.440
HIGH
2.420
LOW
2.350
VOLUME
205.42K
TURNOVER
--
52 WEEK HIGH
6.01
52 WEEK LOW
1.150
MARKET CAP
66.31M
P/E (TTM)
-1.0163
1D
5D
1M
3M
1Y
5Y
1D
Psychedelic: Clearmind reports CMND-100 dosing at Hadassah Medical Center
TipRanks · 1d ago
NRX Pharmaceuticals Is Maintained at Buy by D. Boral Capital
Dow Jones · 2d ago
NRX Pharmaceuticals Price Target Maintained With a $34.00/Share by D. Boral Capital
Dow Jones · 2d ago
D. Boral Capital Maintains Buy on NRX Pharmaceuticals, Maintains $34 Price Target
Benzinga · 2d ago
NRx Pharmaceuticals (NASDAQ: NRXP) Amends IND to Advance NRX-101 With TMS for Depression Treatment
TipRanks · 2d ago
VTI ETF Daily Update—12/03/2025
TipRanks · 3d ago
NRx Pharma Pursues "One-Day" Depression Treatment That Could Be Twice as Effective as Standard Pills
Benzinga · 3d ago
NRx Pharmaceuticals amends IND filing for NRX-101 to include use for TMS
TipRanks · 3d ago
More
About NRXP
NRx Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company developing therapeutics based on its N-methyl-D-aspartate (NMDA) platform for the treatment of central nervous system disorders, specifically suicidal depression, chronic pain, and PTSD. It is developing NRX-100 (preservative-free intravenous ketamine) and NRX-101, (oral D-cycloserine/lurasidone). NRX-100 has been awarded Fast Track Designation for the treatment of Suicidal Ideation in Depression, including Bipolar Depression. NRX-101 has been awarded Breakthrough Therapy Designation for the treatment of suicidal bipolar depression. NRx has filed an Abbreviated New Drug Application (ANDA) and initiated a New Drug Application filing for NRX-100 (IV ketamine) with an application for the Commissioner’s National Priority Voucher Program for the treatment of suicidal depression. Its subsidiary, HOPE Therapeutics, Inc., is a healthcare delivery company that is building a network of interventional psychiatry clinics.

Webull offers NRX Pharmaceuticals Inc stock information, including NASDAQ: NRXP real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, NRXP stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading NRXP stock methods without spending real money on the virtual paper trading platform.